255
Participants
Start Date
August 15, 2020
Primary Completion Date
July 12, 2022
Study Completion Date
June 1, 2025
Concurrent Chemoradiotherapy
"Radiotherapy:~50Gy in 25 fractions to the primary tumor and to mesorectal, presacral,and internal iliac lymph nodes.~Concurrent chemotherapy:~Capecitabine 1650 mg/m2/d"
XELOX
"Intravenous infusion of oxaliplatin (130 mg/m2 over 2 h) on day 1 and oral administration of capecitabine (1000 mg/m2 twice daily) from day 1 to day 14, is repeated every 3 weeks for 6 cycles.~6 courses,3 weeks per course"
mFOLFOX
Administration of l-LV (400 mg/m2) and oxaliplatin (85 mg/ m2) by intravenous infusion over 2 h, followed by rapid intravenous infusion (iv) of 5-FU (400 mg/m2) and then slow infusion (civ) of 5-FU (2400 mg/m2 over 46 h), is repeated every 2 weeks for 9 cycles.
TME
Total mesorectal excision
Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing
Peking University Cancer Hospital & Institute
OTHER
Peking Union Medical College Hospital
OTHER
Jilin Provincial Tumor Hospital
OTHER
Cancer Hospital of Guizhou Province
OTHER
Xijing Hospital
OTHER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER